Cecilia Anna Fidanza

Erythroid hypoplasia among patients with myelodysplastic neoplasms.

Cecilia Anna Fidanza, Wilma Barcellini, Bruno Fattizzo

it (code pays fourni par la source)

GVHD in the era of checkpoint inhibition in Hodgkin lymphoma

Cecilia Anna Fidanza, Fabio Serpenti, Francesca Cavallaro, Kordelia Barbullushi et autres

Allogeneic hematopoietic cell transplantation (alloHCT) remains a potential curative option for patients with relapse/refractory (R/R) Hodgkin lymphoma (HL).1,2 The effective bridge to alloHCT with immune checkpoint inhibitors (ICIs) is known to be associated with increased transplant morbidity and mortality.3,4 We have read …

it (code pays fourni par la source)

A case report of vanishing bile duct syndrome and diffuse large b cell lymphoma: An uncommon association

Cecilia Anna Fidanza, Ramona Cassin, Francesca Cavallaro, Giorgio Alberto Croci et autres

• Paraneoplastic cholestasis is an uncommon presenting symptom in lymphomas. • Vanishing bile duct syndrome (VBDS) is a rare, potentially irreversible acquired ductopenic disease. • A timely treatment of underlying disorder is crucial to prevent poor outcome. We report a rare case …

it (code pays fourni par la source)

Donor Lymphocyte Infusions in Acute Lymphoblastic Leukemia: A Single-Center Retrospective Analysis

Fabio Serpenti, Cecilia Anna Fidanza, Kordelia Barbullushi, Francesca Cavallaro et autres

Introduction Post-allogeneic hematopoietic cell transplantation (allo-HCT) relapse of acute lymphoblastic leukemia (ALL) is associated with a median overall survival (OS) inferior to 6 months. Limited evidence is available on the use of donor lymphocyte infusion (DLI) in ALL. In the setting of …

it (code pays fourni par la source)

Characterization of Complement and Immunoglobulin Deposition in Bone Marrow Trephine Biopsies of Patients with Cytopenias

Cecilia Anna Fidanza, Marta Bortolotti, Giorgio Alberto Croci, Wilma Barcellini et autres

Cytopenias can be categorized in “peripheral”, such as autoimmune hemolytic anemias (AIHA), immune thrombocytopenic purpura (ITP), and chronic idiopathic/autoimmune neutropenia (CIN/AIN), and “central”, including disorders such as aplastic anemia (AA) and myelodysplastic neoplasms (MDS). Several overlaps exist between the two forms, with …

it (code pays fourni par la source)

Red cell distribution width and prognosis in myelofibrosis patients treated with ruxolitinib

Daniele Cattaneo, Nicole Galli, Cristina Bucelli, Cecilia Anna Fidanza et autres

it (code pays fourni par la source)

FEASIBILITY AND SAFETY OF HIGH‐DOSE METHOTREXATE INTERCALATED WITH R‐CHOP IN DIFFUSE LARGE B‐CELL LYMPHOMA: A SINGLE‐CENTER EXPERIENCE

Nicolò Rampi, Ramona Cassin, Cecilia Anna Fidanza, Nicola Cecchi et autres

Background: Central nervous system (CNS) relapse still represents an often-fatal event in diffuse large B cell lymphoma (DLBCL). Efforts to prevent it aimed to identify higher risk patients and to administer adequate prophylaxis. In this setting, unmet needs such as the type …

it (code pays fourni par la source)

POST‐TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS (PTLD) AFTER SOLID ORGAN TRANSPLANTATION (SOT): 15 YEARS OF MONOCENTRIC EXPERIENCE IN A REFERRAL CENTRE

Ramona Cassin, Nicolò Rampi, Cecilia Anna Fidanza, Francesca Cavallaro et autres

Background: Post-transplant lymphoproliferative disorder (PTLD) is a rare complication of solid organ transplantation (SOT) and is composed of a heterogeneous spectrum of predominantly B-cell disorders. Epstein-Barr Virus (EBV) is involved in a substantial number of cases. In this single Center retrospective analysis …

it (code pays fourni par la source)

Real-Life Outcome of Patients with Newly Diagnosed Symptomatic Multiple Myeloma Treated with VTD Induction Followed By Single or Double ASCT: A Retrospective Analysis from a Single Institution

Fabio Serpenti, Anushka Shankar, Nicolò Rampi, Cristina Mocellin et autres

Bortezomib, thalidomide, and dexamethasone (VTD) combination followed by consolidation with autologous haematopoietic cell transplantation (ASCT) has been an established induction regimen for newly diagnosed multiple myeloma (MM) for many years. Recently, long-term follow-up results of Italian phase 3 trial showed an impressive …

it (code pays fourni par la source)

Reply to “successful early use of anti‐SARS‐CoV‐2 monoclonal neutralizing antibodies in SARS‐CoV‐2 infected hematological patients—A Czech multicenter experience”: A case series of SARS‐CoV‐2 Omicron infection and aggressive lymphoma in the Sotrovimab era

Ramona Cassin, Nicolò Rampi, Cecilia Anna Fidanza, Antonio Muscatello et autres

A prospective multicentre experience of early administration of anti-SARS-CoV-2 spike protein neutralizing monoclonal antibodies (MA) with efficacy among patients with hematological malignancies and early-stage COVID- 19 was reported by Weinbergerová et al. The study validated the safety and efficacy of MA early …

it (code pays fourni par la source)